Sexually dimorphic development of the mammalian reproductive tract requires Wnt-7a

被引:256
作者
Parr, BA [1 ]
McMahon, AP [1 ]
机构
[1] Harvard Univ, Dept Mol & Cellular Biol, Biolabs, Cambridge, MA 02138 USA
关键词
D O I
10.1038/27221
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
An important feature of mammalian development is the generation of sexually dimorphic reproductive tracts from the Mullerian and Wolffian ducts. In females, Mullerian ducts develop into the oviduct, uterus, cervix and upper vagina, whereas Wolffian ducts regress. In males, testosterone promotes differentiation of Wolffian ducts into the epididymis, vas deferens and seminal vesicle. The Sertoli cells of the testes produce Mullerian-inhibiting substance, which stimulates Mullerian duct regression in males(1-4) The receptor for Mullerian-inhibiting substance is expressed by mesenchymal cells underlying the Mullerian duct that are thought to mediate regression of the duct(5-7). Mutations that inactivate either Mullerian-inhibiting substance or its receptor allow development of the female reproductive tract in males(8-12). These pseudohermaphrodites are frequently infertile because sperm passage is blocked by the presence of the female reproductive system(9,10,12). Here we show that male mice lacking the signalling molecule Wnt-7a fail to undergo regression of the Mullerian duct as a result of the absence of the receptor for Mullerian-inhibiting substance. Wnt7a-deficient females are infertile because of abnormal development of the oviduct and uterus, both of which are Mullerian duct derivatives. Therefore, we propose that signalling by Wnt-7a allows sexually dimorphic development of the Mullerian ducts.
引用
收藏
页码:707 / 710
页数:4
相关论文
共 24 条
  • [1] BAARENDS WM, 1994, DEVELOPMENT, V120, P189
  • [2] MULLERIAN-INHIBITING SUBSTANCE FUNCTION DURING MAMMALIAN SEXUAL DEVELOPMENT
    BEHRINGER, RR
    FINEGOLD, MJ
    CATE, RL
    [J]. CELL, 1994, 79 (03) : 415 - 425
  • [3] Wnt signaling: a common theme in animal development
    Cadigan, KM
    Nusse, R
    [J]. GENES & DEVELOPMENT, 1997, 11 (24) : 3286 - 3305
  • [4] ISOLATION OF THE BOVINE AND HUMAN GENES FOR MULLERIAN INHIBITING SUBSTANCE AND EXPRESSION OF THE HUMAN-GENE IN ANIMAL-CELLS
    CATE, RL
    MATTALIANO, RJ
    HESSION, C
    TIZARD, R
    FARBER, NM
    CHEUNG, A
    NINFA, EG
    FREY, AZ
    GASH, DJ
    CHOW, EP
    FISHER, RA
    BERTONIS, JM
    TORRES, G
    WALLNER, BP
    RAMACHANDRAN, KL
    RAGIN, RC
    MANGANARO, TF
    MACLAUGHLIN, DT
    DONAHOE, PK
    [J]. CELL, 1986, 45 (05) : 685 - 698
  • [5] Cygan JA, 1997, DEVELOPMENT, V124, P5021
  • [6] CLONING, EXPRESSION, AND ALTERNATIVE SPLICING OF THE RECEPTOR FOR ANTI-MULLERIAN HORMONE
    DICLEMENTE, N
    WILSON, C
    FAURE, E
    BOUSSIN, L
    CARMILLO, P
    TIZARD, R
    PICARD, JY
    VIGIER, B
    JOSSO, N
    CATE, R
    [J]. MOLECULAR ENDOCRINOLOGY, 1994, 8 (08) : 1006 - 1020
  • [7] A 27 base-pair deletion of the anti-Mullerian type II receptor gene is the most common cause of the persistent Mullerian duct syndrome
    Imbeaud, S
    Belville, C
    MessikaZeitoun, L
    Rey, R
    diClemente, N
    Josso, N
    Picard, JY
    [J]. HUMAN MOLECULAR GENETICS, 1996, 5 (09) : 1269 - 1277
  • [8] Clinical aspects and molecular genetics of the persistent Mullerian duct syndrome
    Josso, N
    Picard, JY
    Imbeaud, S
    diClemente, N
    Rey, R
    [J]. CLINICAL ENDOCRINOLOGY, 1997, 47 (02) : 137 - 144
  • [9] JOSSO N, 1993, RECENT PROG HORM RES, V48, P1
  • [10] JOST A, 1953, RECENT PROG HORM RES, V8, P379